Profil

WATAR Florence

Unilab > Bone and cartilage markers laboratory

See author's contact details
Main Referenced Co-authors
Cavalier, Etienne  (6)
Beaudart, Charlotte  (5)
Bruyère, Olivier  (5)
Buckinx, Fanny  (5)
Kovacs, Stéphanie  (5)
Main Referenced Keywords
KDIGO (1); Parathyroid hormone (1); PTH (1); Reference value (1);
Main Referenced Disciplines
General & internal medicine (4)
Laboratory medicine & medical technology (2)

Publications (total 6)

The most downloaded
5 downloads
CAVALIER, E., Piron, C., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., LE GOFF, C., & Reginster, J.-Y. (April 2016). Evaluation of the intra-individual variability of myostatin and activin A, two biomarkers of sarcopenia: impact on the least significant change and followup of the patients. Osteoporosis International, 27 (supplement 1), 56. https://hdl.handle.net/2268/195531

The most cited

9 citations (Scopus®)

Cavalier, E., Salse, M., Dupuy, A.-M., Bargnoux, A.-S., WATAR, F., Souberbielle, J.-C., DELANAYE, P., & Cristol, J.-P. (April 2018). Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse(R) G whole PTH (3rd generation) assay. Clinical Biochemistry, 54, 119-122. doi:10.1016/j.clinbiochem.2018.02.019 https://hdl.handle.net/2268/226143

Cavalier, E., Salse, M., Dupuy, A.-M., Bargnoux, A.-S., WATAR, F., Souberbielle, J.-C., DELANAYE, P., & Cristol, J.-P. (April 2018). Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse(R) G whole PTH (3rd generation) assay. Clinical Biochemistry, 54, 119-122. doi:10.1016/j.clinbiochem.2018.02.019
Peer Reviewed verified by ORBi

CAVALIER, E., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., LE GOFF, C., & Reginster, J.-Y. (16 April 2016). Evaluation of the intra-individual variability of Myostatin and Activin A (and PIIINP): impact on the least significant change and follow-up of the patients [Paper presentation]. World Congresse on Osteoporosis Osteoarthritis and musculoskeletal diseases, Malaga, Spain.

CAVALIER, E., Piron, C., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., LE GOFF, C., & Reginster, J.-Y. (April 2016). Evaluation of the intra-individual variability of myostatin and activin A, two biomarkers of sarcopenia: impact on the least significant change and followup of the patients. Osteoporosis International, 27 (supplement 1), 56.
Peer Reviewed verified by ORBi

CAVALIER, E., CARLISI, I., KOVACS, S., WATAR, F., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J.-Y. (April 2016). Brain-derived neurotrophic factor (BDNF) in normal healthy and hemodialyzed populations. Osteoporosis International, 27 (Supplement 1), 512.
Peer Reviewed verified by ORBi

CAVALIER, E., Carlisi, A. S., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J.-Y. (2016). Brain-derived neurotrophic factor (BDNF) in normal healthy and hemodialyzed populations. Journal of Frailty and Aging, 5 (Supplement 1), 116.
Peer Reviewed verified by ORBi

CAVALIER, E., Piron, C., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., LE GOFF, C., & Reginster, J.-Y. (2016). Evaluation of the intra-individual variability of myostatin and activin A, two biomarkers of sarcopenia. Impact of the least significant change and follow-up of the patients. Journal of Frailty and Aging, 5 (Supplement 1), 82.
Peer Reviewed verified by ORBi

Contact ORBi